[go: up one dir, main page]

DK1641803T3 - Thienopyrimidinderivater som kaliumkanalinhibitorer - Google Patents

Thienopyrimidinderivater som kaliumkanalinhibitorer

Info

Publication number
DK1641803T3
DK1641803T3 DK04736524T DK04736524T DK1641803T3 DK 1641803 T3 DK1641803 T3 DK 1641803T3 DK 04736524 T DK04736524 T DK 04736524T DK 04736524 T DK04736524 T DK 04736524T DK 1641803 T3 DK1641803 T3 DK 1641803T3
Authority
DK
Denmark
Prior art keywords
potassium channel
channel inhibitors
thienopyrimidine derivatives
thienopyrimidine
derivatives
Prior art date
Application number
DK04736524T
Other languages
English (en)
Inventor
John Ford
Nicholas John Palmer
John Frederick Atherall
David John Madge
Brad Sherborne
Mark Bushfield
Edward Benedict Stevens
Original Assignee
Xention Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB0315950.6A external-priority patent/GB0315950D0/en
Application filed by Xention Ltd filed Critical Xention Ltd
Application granted granted Critical
Publication of DK1641803T3 publication Critical patent/DK1641803T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK04736524T 2003-06-11 2004-06-10 Thienopyrimidinderivater som kaliumkanalinhibitorer DK1641803T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US47751803P 2003-06-11 2003-06-11
GBGB0315950.6A GB0315950D0 (en) 2003-06-11 2003-06-11 Compounds
PCT/GB2004/002454 WO2004111057A1 (en) 2003-06-11 2004-06-10 Thienopyrimidine derivatives as potassium channel inhibitors

Publications (1)

Publication Number Publication Date
DK1641803T3 true DK1641803T3 (da) 2009-06-29

Family

ID=33554173

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04736524T DK1641803T3 (da) 2003-06-11 2004-06-10 Thienopyrimidinderivater som kaliumkanalinhibitorer

Country Status (15)

Country Link
EP (1) EP1641803B3 (da)
KR (1) KR101186678B1 (da)
CN (1) CN1823071B (da)
AT (1) ATE425982T1 (da)
AU (1) AU2004247470B2 (da)
BR (1) BRPI0411239A (da)
CA (1) CA2528848C (da)
DE (1) DE602004020070D1 (da)
DK (1) DK1641803T3 (da)
ES (1) ES2324536T7 (da)
MX (1) MXPA05013549A (da)
PL (1) PL1641803T6 (da)
SI (1) SI1641803T1 (da)
WO (1) WO2004111057A1 (da)
ZA (1) ZA200600225B (da)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0315950D0 (en) 2003-06-11 2003-08-13 Xention Discovery Ltd Compounds
US7776867B2 (en) 2004-06-29 2010-08-17 Amgen Inc. Furanopyrimidines
KR20140094626A (ko) * 2004-10-21 2014-07-30 다우 아그로사이언시즈 엘엘씨 살진균 활성을 갖는 티에노-피리미딘 화합물
US7576212B2 (en) 2004-12-09 2009-08-18 Xention Limited Thieno[2,3-B] pyridines as potassium channel inhibitors
US7576080B2 (en) 2004-12-23 2009-08-18 Memory Pharmaceuticals Corporation Certain thienopyrimidine derivatives as phosphodiesterase 10 inhibitors
US7915410B2 (en) 2005-09-09 2011-03-29 Bristol-Myers Squibb Company Acyclic IKur inhibitors
GB0525164D0 (en) 2005-12-09 2006-01-18 Xention Discovery Ltd Compounds
DE102007027800A1 (de) 2007-06-16 2008-12-18 Bayer Healthcare Ag Substituierte bicyclische Heteroaryl-Verbindungen und ihre Verwendung
WO2010048287A2 (en) 2008-10-22 2010-04-29 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Radioprotective agents
EP2405973B1 (en) 2009-03-13 2015-04-22 Katholieke Universiteit Leuven, K.U. Leuven R&D Thiazolopyrimidine modulators as immunosuppressive agents
US8575184B2 (en) 2009-09-03 2013-11-05 Bristol-Myers Squibb Company Quinazolines as potassium ion channel inhibitors
MA34064B1 (fr) * 2010-02-17 2013-03-05 Takeda Pharmaceutical Compose heterocyclique
GB201012889D0 (en) 2010-08-02 2010-09-15 Univ Leuven Kath Antiviral activity of novel bicyclic heterocycles
GB201015411D0 (en) 2010-09-15 2010-10-27 Univ Leuven Kath Anti-cancer activity of novel bicyclic heterocycles
WO2012044993A1 (en) * 2010-09-30 2012-04-05 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Compounds, pharmaceutical compositions, and methods of treating or preventing neurodegenerative diseases or disorders
GB201105659D0 (en) * 2011-04-01 2011-05-18 Xention Ltd Compounds
NO3175985T3 (da) 2011-07-01 2018-04-28
AR090037A1 (es) * 2011-11-15 2014-10-15 Xention Ltd Derivados de tieno y/o furo-pirimidinas y piridinas inhibidores de los canales de potasio
EP2780344A1 (en) * 2011-11-15 2014-09-24 Xention Limited Thieno [2, 3 - c]pyrazoles for use as potassium channel inhibitors
CA2855446C (en) 2011-11-23 2021-04-20 Cancer Research Technology Limited Thienopyrimidine inhibitors of atypical protein kinase c
JP2015504923A (ja) 2012-01-27 2015-02-16 ギリアード サイエンシーズ, インコーポレイテッド 後期ナトリウムイオンチャネル遮断剤およびカリウムイオンチャネル遮断剤を使用する併用療法
WO2014134419A1 (en) 2013-03-01 2014-09-04 Gilead Sciences, Inc. Use of ikach blockers for the treatment of cardiac diseases
US20160002273A1 (en) * 2013-03-07 2016-01-07 Glaxosmithkline Llc Thieno[3,2-d]pyrimidine-6-carboxamides and analogues as sirtuin modulators
FR3015483B1 (fr) * 2013-12-23 2016-01-01 Servier Lab Nouveaux derives de thienopyrimidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
CN106727587A (zh) * 2016-11-28 2017-05-31 李娜 一种治疗心律失常的药物组合物
MX2019014875A (es) * 2017-06-21 2021-01-29 SHY Therapeutics LLC Compuestos que interaccionan con la superfamilia ras para el tratamiento de cancer, enfermedades inflamatorias, rasopatias y enfermedad fibrotica.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD248593A1 (de) * 1985-01-11 1987-08-12 Univ Halle Wittenberg Verfahren zur herstellung von 4-basischsubstituierten thieno/2,3-d/pyrimidin-6-ylcarbonsaeureestern
JP2003518101A (ja) 1999-12-21 2003-06-03 アイカゲン インコーポレイテッド カリウムチャネル阻害剤
US6566380B2 (en) 2000-07-25 2003-05-20 Icagen, Inc. Potassium channel inhibitors
US6849634B2 (en) * 2000-12-21 2005-02-01 Icagen Potassium channel inhibitors

Also Published As

Publication number Publication date
MXPA05013549A (es) 2006-04-05
PL1641803T3 (pl) 2009-08-31
AU2004247470B2 (en) 2009-04-23
SI1641803T1 (sl) 2009-08-31
PL1641803T6 (pl) 2011-04-29
CN1823071A (zh) 2006-08-23
AU2004247470A1 (en) 2004-12-23
CA2528848C (en) 2012-09-04
CA2528848A1 (en) 2004-12-23
ZA200600225B (en) 2007-04-25
KR101186678B1 (ko) 2012-09-27
KR20060057539A (ko) 2006-05-26
ATE425982T1 (de) 2009-04-15
ES2324536T7 (es) 2012-03-16
ES2324536T3 (es) 2009-08-10
EP1641803B3 (en) 2010-12-08
WO2004111057A1 (en) 2004-12-23
BRPI0411239A (pt) 2006-07-18
EP1641803A1 (en) 2006-04-05
DE602004020070D1 (de) 2010-10-07
CN1823071B (zh) 2012-12-19
HK1093064A1 (en) 2007-02-23
EP1641803B1 (en) 2009-03-18

Similar Documents

Publication Publication Date Title
DK1641803T3 (da) Thienopyrimidinderivater som kaliumkanalinhibitorer
NO2020031I1 (no) kobimetinib, inklusive farmasøytisk akseptable salter og solvater, særlig kobimetinib hemifumarat
SE0301700D0 (sv) Novel compounds
NO20071078L (no) Antivirale forbindelser
NO20070866L (no) Antivirale forbindelser.
NO20076447L (no) Bicykliske derivater som modulatorer av ionekanaler
TW200600087A (en) Methods and compositions for treating amyloid-related diseases
MXPA05013977A (es) Metodos y composiciones para tratar enfermedades relacionadas con amiloide.
SG161318A1 (en) Heterocyclic inhibitors of mek and methods of use thereof
IL181271A0 (en) Triazolophthalazine derivatives and pharmaceutical compositions containing the same
SE0302811D0 (sv) Novel compounds
EA200501928A1 (ru) Пирролодигидроизохинолины как ингибиторы pde10
NO20061092L (no) Heteroarvlaminosulfonvlfenvl-derivater for anvendelse som natrium- eller kalslumkanalblokkere i behandlingen av smerte
SE0301653D0 (sv) Novel compounds
DE502004002571D1 (de) Substituierte 3-pyrrolidin-indol-derivate
CL2004001678A1 (es) Compuestos derivados de oxazolidinona; composicion farmaceutica; y uso de los compuestos como agentes bacterianos.
SE0302546D0 (sv) New compounds
NO20063293L (no) Farmasoytiske forbindelser
NO20055612L (no) Anti-inflammatoriske fosfonatforbindelser
MEP34308A (en) Oral formulations of cladribine
SE0300457D0 (sv) Novel compounds
UA96742C2 (en) Mek inhibitors and use thereof
ZA200605653B (en) Proline derivatives used as pharmaceutical active ingredients for the treatment of tumours
ECSP077207A (es) Indolil alquil amino derivados sustituidos como nuevos inhibidores de la histona desacetilasa